March 24, 2021 — Guerbet announced positive results from two Phase III clinical studies comparing the diagnostic efficacy and safety of Gadopiclenol to Gadobutrol in a wide range of indications, covering the central nervous system and various other an

March 24, 2021 — RSIP Vision, a leading innovator in medical imaging through advanced artificial intelligence (AI) and computer vision solutions, announced an advanced joint segmentation tool for detailed, non-invasive planning of revision arthroplasty and other orthopedic procedures for patients with pre-existing

March 23, 2021 — GE Healthcare announced 510(k) clearance from U.S. FDA for OEC 3D, a new surgical imaging system capable of 3-D and 2-D imaging. OEC 3D will set a standard for interoperative 3-D imaging with precise volumetric images for spine and orthopedic procedures. This new system combines the benefits and familiarity of 2-D imaging with greater efficiency to increase access and usability to 3-D.

March 23, 2021 — The first known study exploring optimal outpatient exam scheduling through a model algorithm was shown to yield shorter wait times for magnetic resonance imaging (MRI) for patients and reduced costs.

March 23, 2021 — The science behind the COVID-19 vaccine has the potential to do more than prevent cases of COVID-19 itself. In the coming years, it could also help doctors treat stubborn forms of cancer.

March 23, 2021 — Improved options for cancer treatment are on the way, thanks to a new system developed at Los Alamos National Laboratory for producing alpha-emitting medical radioisotopes intended to target and overpower diseased tissue while sparing the healthy tissue around it.

March 23, 2021 — iCad announced that ProFound AI Version 3.0 for Digital Breast Tomosynthesis (DBT) was cleared by the U.S. Food and Drug Administration (FDA).

March 22, 2021 — Researchers at Charité - Universitätsmedizin Berlin and TU Berlin as well as the University of Oslo have developed a new tissue-section analysis system for diagnosing breast cancer based on artificial intelligence (AI).

Chemical substances that improve the visibility of specific organs, tissues, or blood vessels during a diagnostic or interventional imaging investigation are known as contrast agents.

March 22, 2021 — Moscow Center for Diagnostics & Telemedicine and RADLogics shared the results of a large-scale study (Moscow Experiment on the Computer Vision for the Analysis of Medical Images - mosmed.ai, NCT04489992) conducted by the Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now